Original language | English |
---|---|
Pages (from-to) | 48-48 |
Number of pages | 1 |
Journal | Asia-Pacific Journal of Clinical Oncology |
Volume | 14 |
Publication status | Published - Aug 2018 |
Phase 3 Randomized Eortc 1325-Mg/Keynote-054 Study Results: Pembrolizumab Versus Placebo after Complete Resection in Patients with High-Risk Stage III Melanoma
A. Khattak, C. Robert, C. U. Blank, M. Mandala, G. V. Long, V. Atkinson, S. Dalle, A. Haydon, M. Lichinitser, M. S. Carlino, S. Sandhu, J. Larkin, S. Puig, P. A. Ascierto, P. Rutkowski, D. Schadendorf, P. Lorigan, N. Ibrahim, S. Suciu, A. M. M. Eggermont
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review